NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 40, Issue 1, 2013, Pages 12-17

  Zhang, Lin ^a   Xu, Tianyuan ^a   Wang, Shuang ^a   Yu, Lanqing ^a   Liu, Dexiang ^a   Zhan, Renzhi ^a,b   Yu, Shu Yan ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Provincial Key Laboratory of Mental Disorders   (China)

Author keywords

Antidepressant; Curcumin; Forced swim test; GluN2B; NMDA receptor

Indexed keywords

4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; CURCUMIN; CYCLOSERINE; FLUOXETINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CURCUMA LONGA; DEPRESSION; DRUG DOSE COMPARISON; DRUG POTENTIATION; DRUG STRUCTURE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; RECEPTOR UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CURCUMIN; DEPRESSION; DEPRESSIVE DISORDER; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE; SWIMMING;

EID: 84867901229     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.08.017     Document Type: Article

References (35)

1. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41:40-59.
2. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006, 7:137-151.
3. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
4. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 2008, 33(2):320-331.
5. Castaneda A.E., Tuulio-Henriksson A., Marttunen M., Suvisaari J., Lönnqvist J. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008, 106:1-27.
6. Curlik D.M., Shors T.J. Learning increases the survival of newborn neurons provided that learning is difficult to achieve and successful. J Cogn Neurosci 2011, 23(9):2159-2170.
7. Dalton G.L., Ma L.M., Phillips A.G., Floresco S.B. Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning. Psychopharmacology 2011, 216:525-535.
8. Dalton G.L., Wu D.C., Wang Y.T., Floresco S.B., Phillips A.G. NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear. Neuropharmacology 2012, 62:797-806.
9. Dong S., Zeng Q., Mitchell E.S., Xiu J., Duan Y., Li C., et al. Curcumin enhances neurogenesis and cognition in aged rats: implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One 2012, 7:e31211.
10. Duffy S., Labrie V., Roder J.C. D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacology 2008, 33:1004-1018.
11. Fox C.J., Russell K.I., Wang Y.T., Christie B.R. Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo. Hippocampus 2006, 16:907-915.
12. Goosens K.A., Maren S. NMDA receptors are essential for the acquisition, but not expression, of conditional fear and associative spike firing in the lateral amygdale. Eur J Neurosci 2004, 20:537-548.
13. Izumi Y., Auberson Y.P., Zorumski C.F. Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci 2006, 26:7181-7188.
14. Kim J., Lee S., Park K., Hong I., Song B., Son G., et al. Amygdala depotentiation and fear extinction. Proc Natl Acad Sci 2007, 104:20955-20960.
15. Kulkarni S.K., Bhutani M.K., Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 2008, 201:435-442.
16. Lin T.Y., Lu C.W., Wang C.C., Wang Y.C., Wang S.J. Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1785-1793.
17. Liu L., Wong L.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304:1021-1024.
18. Maheshwari R.K., Singh A.K., Gaddipati J., Smiral R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
19. Melo T.G., Izídio G.S., Ferreira L.S., Sousa D.S., Macedo P.T., Cabral A., et al. Antidepressants differentially modify the extinction of an aversive memory task in female rats. Prog Neuropsychopharmacol Biol Psychiatry 2012, 37:33-40.
20. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 2007, 41:189-206.
21. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
22. Porsolt R.D., Pichon M.L.E., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressant. Arch Int Pharmacodyn Ther 1977, 229:327-336.
23. Rosenzweig-Lipson S., Beyer C.E., Hughes Z.A., Khawaja X., Rajarao S.J., Malberg J.E., et al. Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther 2007, 113:134-153.
24. Schulz D., Buddenberg T., Huston J.P. Extinction-induced "despair" in the water maze, exploratory behavior and fear: effects of chronic antidepressant treatment. Neurobiol Learn Mem 2007, 87:624-634.
25. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., et al. Genetic enhancement of learning and memory in mice. Nature 1999, 401:25-27.
26. Van der Watt G., Laugharne J., Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry 2008, 21:37-42.
27. Walker D.L., Ressler K.J., Lu K.T., Davis M. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002, 22:2343-2351.
28. Wang R., Xu Y., Wu H.L., Li Y.B., Li Y.H., Guo J.B. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol 2008, 578:43-50.
29. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H. The effects of curcumin on depressive-like behaviors in mice. Eur J Pharmacol 2005, 518:40-46.
30. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 2005, 82:200-206.
31. Xu Y., Lin D., Li S., Li G., Shyamala S.G., Barish P.A., et al. Curcumin reverses impaired cognition and neuronal plasticity induced by chronic stress. Neuropharmacology 2009, 57:463-471.
32. Yang C.H., Huang C.C., Hsu K.S. Behavioral stress enhances hippocampal CA1 long-term depression through the blockade of the glutamate uptake. J Neurosci 2005, 25:4288-4293.
33. Yu S.Y., Wu D.C., Liu L., Ge Y., Wang Y.T. Role of AMPA receptor trafficking in NMDA receptor-dependent synaptic plasticity in the rat lateral amygdala. J Neurochem 2008, 106:889-899.
34. Yu S.Y., Wu D.C., Zhan R.Z. GluN2B subunits of the NMDA receptor contribute to the AMPA receptor internalization during long-term depression in the lateral amygdala of juvenile rats. Neuroscience 2010, 171:1102-1108.
35. Zhou H., Beevers C.S., Huang S. The targets of curcumin. Curr Drug Targets 2011, 12:332-347.